Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03786432 · ClinicalTrials.gov registry record · NA
Prospective Study of Fusion Rates Using Spira-C Device for Anterior Cervical Discectomy and Fusion Surgery
A NA study, sponsored by Corewell Health East.
- Terminated
- Registry status
- NA
- Development phase
- 13
- Enrollment target
NCT03786432 is a NA study that was terminated before completion, run by Corewell Health East. The registered enrollment target is 13 participants.
The verdict
NCT03786432, a NA study, was terminated before completion, sponsored by Corewell Health East.
- TERMINATED
- Registry status
- NA
- Development phase
- 13 participants
- Enrollment target
Study Summary
The objective of this study is to perform a prospective, single-arm clinical evaluation utilizing the Spira™-C 3-D printed titanium interbody device for treatment of degenerative disc disease and spinal stenosis of the cervical spine to evaluate fusion status and patient reported outcomes. The primary objective is fusion status or bony healing within the device. Patient reported outcomes, i.e. pain, function, and quality of life will also be measured postoperatively.
Interventions
- DEVICE Spira-C Interbody Device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2019-01-10 |
| Est. Completion | 2022-06-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03786432
The ClinicalTrials.gov registry entry for NCT03786432 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Corewell Health East, which has 106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Spira-C Interbody Device is the first listed.
NCT03786432 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03786432 about?
NCT03786432 is a clinical study titled "Prospective Study of Fusion Rates Using Spira-C Device for Anterior Cervical Discectomy and Fusion Surgery". The objective of this study is to perform a prospective, single-arm clinical evaluation utilizing the Spira™-C 3-D printed titanium interbody device for treatment of degenerative disc disease and spinal stenosis of the cervical spine to evaluate fusion status and patient reported outcomes. The prima...
What is the current status of trial NCT03786432?
This trial is currently terminated. It is a NA study. The enrollment target is 13 participants. The study started on 2019-01-10. Estimated completion is 2022-06-30.
What interventions are being tested in trial NCT03786432?
The interventions under investigation include: Spira-C Interbody Device (DEVICE).
Who is sponsoring clinical trial NCT03786432?
This trial is sponsored by Corewell Health East, which has 106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.